SHOX2 DNA methylation is a validated biomarker in bronchial fluid aspirates and allows for detection of lung cancer, even in patients for which cytopathological examination and bronchoscopy failed to detect malignancy [23, 27]. This evidence concerns the gene SHOX2 and lung carcinoma.